Clinical trial

Predicting Response to Incretin Based Agents in Type 2 Diabetes

NCT01503112

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2011-05-01

PhaseN/A

Study timeline

Study start (unknown)2011-05-01Date precision: month

Registry last updated2018-04-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetesunresolved

Interventions

No intervention, observational studyOTHER

Sponsors & collaborators

Royal Devon and Exeter NHS Foundation Trustlead sponsor

National Institute for Health Research, United Kingdomcollaborator

University of Exetercollaborator

Mapped research locations

OxfordUnited Kingdom1 BristolUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01503112 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.